207 related articles for article (PubMed ID: 21898491)
1. Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury.
Kuriyama N; Duarte S; Hamada T; Busuttil RW; Coito AJ
Hepatology; 2011 Dec; 54(6):2125-36. PubMed ID: 21898491
[TBL] [Abstract][Full Text] [Related]
2. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
[TBL] [Abstract][Full Text] [Related]
3. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
Kato H; Kuriyama N; Duarte S; Clavien PA; Busuttil RW; Coito AJ
J Hepatol; 2014 May; 60(5):1032-9. PubMed ID: 24412604
[TBL] [Abstract][Full Text] [Related]
4. TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.
Duarte S; Hamada T; Kuriyama N; Busuttil RW; Coito AJ
Hepatology; 2012 Sep; 56(3):1074-85. PubMed ID: 22407827
[TBL] [Abstract][Full Text] [Related]
5. Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury.
Shen XD; Ke B; Uchida Y; Ji H; Gao F; Zhai Y; Busuttil RW; Kupiec-Weglinski JW
Liver Transpl; 2011 Feb; 17(2):201-10. PubMed ID: 21280193
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice.
Kato H; Duarte S; Liu D; Busuttil RW; Coito AJ
PLoS One; 2015; 10(9):e0137642. PubMed ID: 26355684
[TBL] [Abstract][Full Text] [Related]
7. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury.
Hamada T; Fondevila C; Busuttil RW; Coito AJ
Hepatology; 2008 Jan; 47(1):186-98. PubMed ID: 17880014
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.
Coito AJ
Curr Opin Organ Transplant; 2011 Feb; 16(1):34-40. PubMed ID: 21150609
[TBL] [Abstract][Full Text] [Related]
10. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.
Shen XD; Ke B; Zhai Y; Gao F; Tsuchihashi S; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
Liver Transpl; 2007 Oct; 13(10):1435-43. PubMed ID: 17902130
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury.
Hui W; Jinxiang Z; Heshui W; Zhuoya L; Qichang Z
Biochem Biophys Res Commun; 2009 Nov; 389(2):328-32. PubMed ID: 19723506
[TBL] [Abstract][Full Text] [Related]
12. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
13. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.
Ke B; Shen XD; Tsuchihashi S; Gao F; Araujo JA; Busuttil RW; Ritter T; Kupiec-Weglinski JW
Hum Gene Ther; 2007 Apr; 18(4):355-66. PubMed ID: 17439357
[TBL] [Abstract][Full Text] [Related]
14. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury.
Hamada T; Duarte S; Tsuchihashi S; Busuttil RW; Coito AJ
Am J Pathol; 2009 Jun; 174(6):2265-77. PubMed ID: 19443702
[TBL] [Abstract][Full Text] [Related]
16. Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration.
Saidi RF; Rajeshkumar B; Shariftabrizi A; Dresser K; Walter O
J Surg Res; 2014 Apr; 187(2):660-6. PubMed ID: 24433870
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury.
Hamada T; Tsuchihashi S; Avanesyan A; Duarte S; Moore C; Busuttil RW; Coito AJ
J Immunol; 2008 Feb; 180(3):1843-53. PubMed ID: 18209082
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice.
Fujimoto M; Shiba M; Kawakita F; Liu L; Shimojo N; Imanaka-Yoshida K; Yoshida T; Suzuki H
J Neurosurg; 2016 Jun; 124(6):1693-702. PubMed ID: 26473781
[TBL] [Abstract][Full Text] [Related]
19. Ischemia and reperfusion liver injury is reduced in the absence of Toll-like receptor 4.
Ben-Ari Z; Avlas O; Fallach R; Schmilovitz-Weiss H; Chepurko Y; Pappo O; Hochhauser E
Cell Physiol Biochem; 2012; 30(2):489-98. PubMed ID: 22797797
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver.
Fujii T; Kuriyama N; Hayasaki A; Iizawa Y; Tanemura A; Kato H; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
Transplant Proc; 2018 Nov; 50(9):2807-2814. PubMed ID: 30401402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
